Evidence map›Paper›PMID 41761390›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2026

Preferences for tongue swab versus sputum collection for TB testing: a multi-country survey.

K M Kumar, A Borkman, A Kim, R Crowder, B Ajide, K Alí-Francia, M Chirwa, L Kamulegeya, H Le, V N Trung and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

K M KumarDepartment of Pulmonary Medicine, Christian Medical College, Vellore, India.
A BorkmanDivision of Infectious Diseases, Medical University of South Carolina, Charleston, SC, USA.
A KimDivision of Pulmonary Diseases and Critical Care Medicine, University of California -Irvine, Irvine, CA, USA.
R CrowderDivision of Pulmonary and Critical Care Medicine, University of California - San Francisco, San Francisco, CA, USA;, Center for Tuberculosis, Institute for Global Health Sciences, University of California - San Francisco, San Francisco, CA, USA.
B AjideBingham University, Karu, Nigeria.
K Alí-FranciaInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
M ChirwaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
L KamulegeyaMakerere University, Kampala, Uganda.
H LeCenter for Promotion of Advancement of Society, Hanoi, Vietnam.
V N TrungVietnam National Lung Hospital, NTP, Hanoi, Vietnam.
R VenterDepartment of Science, Technology and Innovation - National Research Foundation Centre of Excellence for Biomedical TB Research, SAMRC Centre for TB Research, Stellenbosch University, Tygerberg, Cape Town, South Africa, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa.
J BimbaBingham University, Karu, Nigeria.
D J ChristopherDepartment of Pulmonary Medicine, Christian Medical College, Vellore, India.
V DalayDe la Salle Medical and Health Sciences Institute, College of Medicine, Cavite, Philippines.
N Van HungVietnam National Lung Hospital, NTP, Hanoi, Vietnam.
M MuyoyetaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
L NakiyingiMakerere University, Kampala, Uganda.
G TheronDepartment of Science, Technology and Innovation - National Research Foundation Centre of Excellence for Biomedical TB Research, SAMRC Centre for TB Research, Stellenbosch University, Tygerberg, Cape Town, South Africa, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa.
C YuDe la Salle Medical and Health Sciences Institute, College of Medicine, Cavite, Philippines.
C Zamudio-FuertesInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
J AtimGlobal Health Labs, Medical and Clinical Research, Seattle, WA, USA.
A D KerkhoffDivision of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
M Del Mar CastroDepartment of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany;, German Center for Infection Research, Partner site Heidelberg, Heidelberg, Germany.
P NahidCenter for Tuberculosis, Institute for Global Health Sciences, University of California - San Francisco, San Francisco, CA, USA.
C M DenkingerDepartment of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany;, German Center for Infection Research, Partner site Heidelberg, Heidelberg, Germany.
A CattamanchiDivision of Pulmonary Diseases and Critical Care Medicine, University of California -Irvine, Irvine, CA, USA;, Center for Tuberculosis, Institute for Global Health Sciences, University of California - San Francisco, San Francisco, CA, USA.
S E DormanDivision of Infectious Diseases, Medical University of South Carolina, Charleston, SC, USA.
N WestDivision of Pulmonary and Critical Care Medicine, University of California - San Francisco, San Francisco, CA, USA;, Center for Tuberculosis, Institute for Global Health Sciences, University of California - San Francisco, San Francisco, CA, USA.

Funding

FEND for TB supplement to accelerate BLINK X developmentU01AI152084 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ALLAND, DAVID, DORMAN, SUSAN E · 2020 to 2024
$20.0M
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)U01AI152087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA, DENKINGER, CLAUDIA MARIA · 2020 to 2024
$19.3M
NIAID NIH HHS U01 AI152084NIAID NIH HHS U01 AI152087
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41761390
PMCPMC13245111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.